Quaker Chemical CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
Quaker Houghton announced a 10% year-over-year increase in net sales to $532.6 million and a 28% rise in non-GAAP earnings per diluted share to $2.19 for the second quarter of 2026.
NYSE
Quaker Chemical Corporation reports the resignation of its Vice President, Corporate Controller, and Principal Accounting Officer, Steven Dassing, effective July 22, 2026, with CFO Coler assuming the Principal Accounting Officer role.
NYSE
Quaker Chemical Corporation announced the retirement of Chairman Michael F. Barry and the appointment of Mark A. Douglas as the new Chairman, effective May 13, 2026.
NYSE
Quaker Houghton reported an 8% year-over-year increase in Q1 2026 net sales to $480.5 million, driven by organic volume growth and new business wins.
NYSE
Quaker Chemical Corporation has amended its credit agreement, extending debt maturities to 2031 and increasing available revolving credit.
NYSE
Quaker Chemical Corporation announced the departure of Jeffrey Fleck, Senior Vice President, Chief Global Operations Officer, effective March 9, 2026.
NYSE
Quaker Houghton announced its fourth quarter 2025 results showing increased profitability, but full year GAAP results reflected a net loss due to significant charges.
NYSE
Quaker Houghton announced robust third-quarter 2025 non-GAAP results, with increased sales and adjusted EBITDA, despite persistent soft end market conditions.
NYSE
Quaker Houghton announced a second quarter 2025 net loss of $66.6 million, primarily due to an $88.8 million goodwill impairment charge, despite a 4% increase in net sales to $483.4 million.
NYSE
Quaker Chemical Corporation announced the voluntary resignation of its Chief Accounting Officer, Jeffrey Kutz, and the appointment of Steve Dassing as Principal Accounting Officer.
NYSE
Ramaswami Seshasayee retired from Quaker Chemical Corporation's Board of Directors, effective May 14, 2025, leading to a reduction in the board size.
NYSE
Quaker Chemical Corporation reports the outcomes of its 2025 Annual Meeting, including the election of directors, approval of executive compensation, and ratification of the accounting firm.
NYSE
Quaker Houghton reports a decrease in net sales and net income for Q1 2025, despite strategic acquisitions and improved earnings compared to the previous quarter.
NYSE
Quaker Houghton finalizes the acquisition of Dipsol Chemicals and announces the acquisition of Natech, Ltd., to bolster its advanced solutions business and global market presence.
NYSE
8-K: Quaker Houghton to Acquire Dipsol Chemicals for $153 Million, Expanding Advanced Solutions Portfolio
Quaker Houghton is set to acquire Dipsol Chemicals for approximately $153 million, aiming to enhance its advanced solutions portfolio and global reach.
NYSE
Quaker Houghton reports a decrease in net sales for Q4 2024, but highlights improved profitability and strong cash flow for the full year.
NYSE
Quaker Chemical Corporation granted special long-term incentive equity compensation awards in the form of restricted stock units to two executive vice presidents, with vesting tied to the company's total shareholder return relative to the S&P 1500 Chemicals Index.
NYSE
Andrew Tometich has officially departed as CEO of Quaker Chemical, with a separation agreement detailing severance and accelerated vesting of equity awards.
NYSE
Quaker Chemical Corporation reports the departure of Melissa Leneis, Senior Vice President and Chief Human Resources Officer, effective December 2, 2024.
NYSE
Quaker Houghton has appointed Joseph Berquist as its new CEO and President, effective November 18, 2024, succeeding Andrew Tometich.
NYSE
Quaker Houghton's third quarter 2024 results show a decrease in net sales and adjusted EBITDA compared to the previous year, primarily due to softening market conditions.
NYSE
Quaker Houghton announced its second quarter 2024 results, showing a 5% increase in adjusted EBITDA year-over-year despite a slight decrease in net sales.
NYSE
Quaker Houghton has appointed Nandita Bakhshi and Lucrce Foufopoulos-De Ridder as new independent directors, effective immediately, increasing the board size to twelve.
NYSE
Quaker Chemical Corporation's shareholders approved an amended long-term performance incentive plan and elected three directors at their annual meeting on May 8, 2024.
NYSE
Quaker Houghton has announced the appointment of Tom Coler as its new Chief Financial Officer, succeeding Shane Hostetter, effective June 10, 2024.
NYSE
Quaker Houghton announced a 6% increase in adjusted EBITDA for Q1 2024, driven by improved gross margins, despite a slight decrease in net sales.
NYSE
Quaker Houghton announced its fourth quarter and full year 2023 results, highlighting record full-year adjusted EBITDA and the approval of a new share repurchase program.